Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Brain Res Mol Brain Res ; 111(1-2): 91-103, 2003 Mar 17.
Artigo em Inglês | MEDLINE | ID: mdl-12654509

RESUMO

Heat shock proteins are expressed in response to cellular stress and can protect cells from further stress and facilitate recovery. Heat shock protein 27 is of particular interest because it has been implicated in a range of protective roles including protein chaperoning, stabilising elements of the cytoskeleton and as an active inhibitor of apoptosis. In the present study, we have examined the potential of administration of exogenous HSP27 to confer protection against KA-induced neuronal cell death in vivo. We aimed to exploit the neurotropic specificity of herpes simplex virus-1 based virus vectors, which have been rendered replication-incompetent, to infect neurons of the hippocampus. The systemic administration of kainic acid, an analogue of glutamate, causes seizures resulting in neuronal damage and is an established animal model of epilepsy. Neuron loss is particularly prominent in the hippocampus and the mode of death is at least partly apoptotic in nature. We show that the overexpression of HSP27 in these neurons can significantly augment their survival following kainic acid administration. In contrast, injection of a control virus expressing beta-galactosidase does not confer protection. This is the first time that protection by exogenously expressed HSP27 has been demonstrated in an in vivo model of neuronal cell death.


Assuntos
Morte Celular/efeitos dos fármacos , Epilepsia/tratamento farmacológico , Vetores Genéticos/farmacologia , Proteínas de Choque Térmico/genética , Degeneração Neural/tratamento farmacológico , Fármacos Neuroprotetores/farmacologia , Estresse Fisiológico/tratamento farmacológico , Animais , Contagem de Células , Morte Celular/fisiologia , Modelos Animais de Doenças , Epilepsia/genética , Epilepsia/metabolismo , Vetores Genéticos/uso terapêutico , Proteínas de Choque Térmico/uso terapêutico , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Hipocampo/patologia , Ácido Caínico/farmacologia , Masculino , Degeneração Neural/genética , Degeneração Neural/metabolismo , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Neurônios/patologia , Fármacos Neuroprotetores/uso terapêutico , Neurotoxinas/farmacologia , Ratos , Ratos Sprague-Dawley , Simplexvirus/genética , Simplexvirus/metabolismo , Simplexvirus/patogenicidade , Estresse Fisiológico/genética , Estresse Fisiológico/metabolismo , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...